COVID-19 Impact

You may see some delays in posting new content due to COVID-19. If you have any questions, please submit a message to PSNet Support.
 

PSNet: Patient Safety Network
Journal Article
Study

Association of current opioid use with serious adverse events among older adult survivors of breast cancer.

Winn AN, Check DK, Farkas A, et al. JAMA Netw Open. 2020;3(9):e2016858.

Chronic opioid use for noncancer pain is a well-established patient safety problem but less is known about chronic use after cancer treatment. This study used ten years of national Medicare surveillance data to assess the risks of serious adverse events associated with continued prescription opioid use after treatment for breast cancer. Findings indicate that opioid use after active cancer treatment was associated with a 15-fold increase in risk of adverse events (including overdose) and an increased risk in adverse events related to opioid use, including falls, fractures, and hospitalization. These findings suggest that practitioners may be able to improve outcomes by closely monitoring and reducing unnecessary long-term opioid use after cancer treatment.